Fruquintinib
-
Catalog numberB1979-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_name(Z)-6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carbimidic acid; HMPL-013
-
DescriptionFruquintinib (HMPL-013) is a potent and selective vascular endothelial growth factor receptors1/2/3 (VEGFR 1/2/3) inhibitor with IC₅₀s of 33, 0.35, and 35 nM, respectively. It only weakly inhibits RET, FGFR-1 and c-kit kinases.
-
CAS Number1194506-26-7
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₁H₁₉N₃O₅
-
Molecular Weight393.39
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>6 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA potent VEGFR inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
PubChem CID44480399
-
SMILESCC1=C(C2=C(O1)C=C(C=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(=O)NC
-
InChiInChI=1S/C21H19N3O5/c1-11-19(20(25)22-2)13-6-5-12(7-16(13)28-11)29-21-14-8-17(26-3)18(27-4)9-15(14)23-10-24-21/h5-10H,1-4H3,(H,22,25)
-
InChi KeyBALLNEJQLSTPIO-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameFruquintinib
-
Alternative nameFruquintinib
-